Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 711

1.

The role of COX-2 inhibition in breast cancer treatment and prevention.

Arun B, Goss P.

Semin Oncol. 2004 Apr;31(2 Suppl 7):22-9. Review.

PMID:
15179621
2.

COX-2 inhibition and lung cancer.

Sandler AB, Dubinett SM.

Semin Oncol. 2004 Apr;31(2 Suppl 7):45-52. Review.

PMID:
15179623
3.

Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.

Cancer Res. 2000 Jan 15;60(2):293-7.

4.

[Cyclooxygenase 2 and breast cancer. From biological concepts to therapeutic trials].

Guastalla JP, Bachelot T, Ray-Coquard I.

Bull Cancer. 2004 May;91 Spec No:S99-108. Review. French.

PMID:
15239337
5.

Cyclooxygenase-2: a potential target in breast cancer.

Wang D, Dubois RN.

Semin Oncol. 2004 Feb;31(1 Suppl 3):64-73. Review.

PMID:
15052544
6.

Breast cancer prevention--clinical trials strategies involving aromatase inhibitors.

Goss PE.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):487-93. Review.

PMID:
14623548
7.
8.

Prognostic impact of cyclooxygenase-2 in breast cancer.

Denkert C, Winzer KJ, Hauptmann S.

Clin Breast Cancer. 2004 Feb;4(6):428-33. Review.

PMID:
15023244
9.

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K.

Cancer Res. 2000 Mar 1;60(5):1306-11.

10.

Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.

Zweifel BS, Davis TW, Ornberg RL, Masferrer JL.

Cancer Res. 2002 Nov 15;62(22):6706-11.

11.

Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?

Sanborn R, Blanke CD.

Semin Oncol. 2005 Feb;32(1):69-75. Review.

PMID:
15726508
12.

Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.

Kismet K, Akay MT, Abbasoglu O, Ercan A.

Cancer Detect Prev. 2004;28(2):127-42. Review.

PMID:
15068837
13.
14.

Prevention strategies with aromatase inhibitors.

Goss PE, Strasser-Weippl K.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):372S-9S.

15.
16.
17.

COX-2: a protein with an active role in gynecological cancers.

Munkarah A, Ali-Fehmi R.

Curr Opin Obstet Gynecol. 2005 Feb;17(1):49-53. Review.

PMID:
15711411
18.

Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis.

Goldenberg MM.

Clin Ther. 1999 Sep;21(9):1497-513; discussion 1427-8. Review.

PMID:
10509845
19.

Approach to angiogenesis inhibition based on cyclooxygenase-2.

Masferrer J.

Cancer J. 2001 Nov-Dec;7 Suppl 3:S144-50. Review.

PMID:
11779086
20.

Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.

Raut CP, Nawrocki S, Lashinger LM, Davis DW, Khanbolooki S, Xiong H, Ellis LM, McConkey DJ.

Cancer Biol Ther. 2004 Dec;3(12):1217-24. Epub 2004 Dec 9.

PMID:
15477758
Items per page

Supplemental Content

Write to the Help Desk